| Market Cap | ₹34Cr |
| ROE | 2.04% |
| P/E Ratio(TTM) | 39.47 |
| EPS(TTM) | 1.14 |
| P/B Ratio | 1.13 |
| Dividend Yield | 0.00% |
| Industry P/E | 39.81 |
| Book Value | 39.72 |
| Debt to Equity | 0.69 |
| Face Value | 10 |
| Parent Organisation | Chandra Bhagat Pharma Limited |
| Managing Director | Hemant Chandravadan Bhagat |
| Founded | 2003 |
| BSE Symbol | 542934 |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| JB Chemicals & Pharmaceuticals | NA (0.00%) | 38.94 | ||
| Emcure Pharmaceuticals | NA (0.00%) | 32.07 | ||
| Wockhardt | NA (0.00%) | -439.39 | ||
| Cohance Lifesciences | NA (0.00%) | 64.75 |